Metraipolis › archive › dc_56ee14f2e46f

Novel therapeutic targets at the crossroad between epigenetics and signal transduction pathways in B-cell lymphomas — Europe PMC PMID:42257744

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42257744
DOI
10.1007/s10238-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-10-31T16:59:36.130Z
SHA-256 of the archived text
2af73a38386bf7077e38aa68305b49428f8d5f0abf7418b14b7c95018108783c
Stable URL of this page
https://metraipolis.com/documento/dc_56ee14f2e46f

How to cite

Novel therapeutic targets at the crossroad between epigenetics and signal transduction pathways in B-cell lymphomas — Europe PMC PMID:42257744 — Europe PMC (en), https://europepmc.org/article/MED/42257744 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_56ee14f2e46f (Metraipolis archive dc_56ee14f2e46f, sha256 2af73a38386bf7077e38aa68305b49428f8d5f0abf7418b14b7c95018108783c)
BibTeX
@misc{dc56ee14f2e46f,
  title = {Novel therapeutic targets at the crossroad between epigenetics and signal transduction pathways in B-cell lymphomas — Europe PMC PMID:42257744},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42257744},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_56ee14f2e46f; sha256 2af73a38386bf7077e38aa68305b49428f8d5f0abf7418b14b7c95018108783c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42257744. Agents can read the archived copy with the MCP tool read_document.